Leisure Capital Management Volitionrx LTD Transaction History

Leisure Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$2.97 - $6.42 $39,367 - $85,097	-13,255 Closed	0 $0
Q2 2019 Jul 10, 2019	SELL	$2.93 - $3.6 $164,320 - $201,895	-56,082 Reduced 80.88%	13,255 $42,000
Q1 2019 May 08, 2019	BUY	$2.19 - $3.45 $6,517 - $10,267	2,976 Added 4.48%	69,337 $225,000
Q4 2018 Feb 13, 2019	SELL	$1.7 - $2.88 $10,400 - $17,619	-6,118 Reduced 8.44%	66,361 $120,000
Q3 2018 Nov 09, 2018	BUY	$1.57 - $2.59 $113,792 - $187,720	72,479 New	72,479 $188,000
Q2 2018 Aug 02, 2018	SELL	$1.88 - $2.41 $138,149 - $177,096	-73,484 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$2.29 - $3.95 $3,157 - $5,447	-1,379 Reduced 1.84%	73,484 $176,000
Q4 2017 Feb 12, 2018	BUY	$2.1 - $3.72 $3,423 - $6,063	1,630 Added 2.23%	74,863 $220,000
Q3 2017 Oct 24, 2017	BUY	$2.45 - $2.98 $179,420 - $218,234	73,233	73,233 $193,000

17.8M

41K

100

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $39M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Leisure Capital Management, based on Form 13F filings with the SEC.

Stay updated on Leisure Capital Management with notifications on news.